RxKinetix, Inc. is an emerging drug delivery company engaged in the research and development of novel pharmaceutical formulations. Its proprietary technology platforms include MicronixTM, which uses supercritical fluid processing to form dry powders, and ProGelzTM, a gel formulation. These technologies are being used to prepare targeted and controlled release formulations of small molecules, peptides and proteins for topical, injected and inhaled routes of administration.
